Recently some cohort clinical trials have shown that the growth differentiation factor 15 (GDF-15), a biomarker released in cardiac and blood wall tissues in response to heart volume expansion or abnormal pressure load, is associated with early diagnosis and bad outcomes in patients with CVD and heart failure [11]. The gene discussed is GDF15; the disease is heart failure.